Drug discontinuation: Emtricitabine Oral Solution (EMTRIVA)
FDA lists 1 presentation as To Be Discontinued. Companies: Gilead Sciences, Inc..
- Published by source
- 2026-06-17
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Gilead Sciences, Inc.
- Products
- Emtricitabine Oral Solution EMTRIVA
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Product expected to be available until March 2027
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-06-17
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1074 | new | 2026-10-22 | 989120992179…346c51 | ff860180de6d…206230 |
Chain head: #1094 edf3be25ec2e…478842